Page last updated: 2024-08-16

phenylpropanolamine and Pulmonary Disease, Chronic Obstructive

phenylpropanolamine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baldock, H; Bunnage, ME; Burrows, J; Clarke, N; Coghlan, M; Entwistle, D; Fairman, D; Feeder, N; Fulton, C; Hilton, L; James, K; Jones, LH; Jones, RM; Kenyon, AS; Marshall, S; Newman, SD; Osborne, R; Patel, S; Price, DA; Selby, MD; Stuart, EF; Trevethick, MA; Wright, KN	1

Other Studies

1 other study(ies) available for phenylpropanolamine and Pulmonary Disease, Chronic Obstructive

Article	Year
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD. Bioorganic & medicinal chemistry letters, 2011, May-01, Volume: 21, Issue:9 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Drug Design; Drug Therapy, Combination; Guinea Pigs; Molecular Structure; Muscarinic Antagonists; Phenylpropanolamine; Pulmonary Disease, Chronic Obstructive; Tolterodine Tartrate	2011

Article

Year

Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD.

Bioorganic & medicinal chemistry letters, 2011, May-01, Volume: 21, Issue:9

Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Drug Design; Drug Therapy, Combination; Guinea Pigs; Molecular Structure; Muscarinic Antagonists; Phenylpropanolamine; Pulmonary Disease, Chronic Obstructive; Tolterodine Tartrate

2011